PCR Technologies Market

The Report "PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), Enduser (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030", to reach USD  21.89 Billion by 2030 from 14.61 Billion in 2024, at a CAGR of 7.0% during 2024–2030.

Browse 237 market data Tables and 68 Figures spread through 304 Pages and in-depth TOC on "PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), Enduser (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pcr-technologies-market-96291811.html

The primary factor driving the market for PCR technologies is the growing need for rapid and accurate diagnostic tools in healthcare, pharmaceutical, and biotechnology industries. In addition, increasing rates of infectious diseases such as COVID-19 have enhanced the use of PCR, since it is accurate and sensitive method for detecting pathogens. Increased use of PCR for genetic testing, oncology, and personalized medicine further supports growth of this market. The digital advancements in technological innovation, real-time PCR, among others, have significantly improved test accuracy and efficiency. Investment in laboratory infrastructural development and government initiatives also drives the market. Research in genomics and molecular biology is on the rise, further supporting market growth.

Reagents and Consumables to Dominate Market in 2023.

Reagents and consumables are the components that ensure effective PCR operations. Important reagents for amplifying target DNA or RNA include primers, buffers, nucleotides (dNTPs), and DNA or RNA polymerases. It usually employs probes in real-time PCR to detect amplified sequences based on fluorescence. The supply of reagents and consumables, such as PCR tubes, microcentrifuge tubes, pipette tips, and sealing materials, will be essential for proper sample handling, maintenance of the reaction conditions, and thus prevention of contamination. As a component of PCR processes and needing to be restocked frequently, the share of the market for reagents and consumables in the PCR technologies market is likely to be considerable.

Growing applications in genetic research, cancer diagnostics, infectious disease diagnosis, and personalized medicine, drives the growth of this market. The demand for use of the different types of reagent, especially for advanced techniques such as digital and real-time PCR,  further supports growth.

Diagnostic Application accounted for the highest market share of 2023.

Due to its high sensitivity and specificity in the diagnosis of various infections, genetic disorders, and markers of cancer, the PCR holds the highest proportion of market share within the diagnostics market. Owing to its capability of detecting even a minute number of pathogens concentrated in a human patient, it has emerged as a diagnostic tool for determining bacterial as well as viral infections such as hepatitis, HIV, COVID-19, and tuberculosis. Additionally, increasing trends of prenatal diagnostics, personalized medicines, and genetic screenings enhances its application. Ongoing developments of PCR technologies in real-time PCR and point-of-care testing,  further supports the growth of this market.

Diagnostic Laboratories remains the largest in 2023.

Diagnostic laboratories are the largest end users of PCR technology and hence have the largest market share. These labs mostly use this technology in the detection and diagnosis of diseases. PCR is a fundamental process in diagnostic labs, and often it is used in the diagnostics of bacterial and viral infections, prenatal testing, cancer and oncology. These laboratories apply PCR technologies because of high-throughput operations and the need to conduct tests repeatedly.

North America Accounts for the Largest Market Share in 2023

North America has accounted for a major portion of the PCR technologies market due to several critical reasons. The region is known for extensive technological innovation and has an exceptionally well-established healthcare infrastructure, which makes wide-scale application of PCR technologies possible in both clinical and research environments. The diagnostics laboratories, research institutes, and pharmaceutical companies have widely used PCR for different requirements like genetic testing, cancer studies, and drug development. North America is also leading in healthcare innovation and research due to great investments in biotechnology and molecular diagnostics. The demand for PCR increases due infectious diseases, chronic disorders, and genetic disorders , and it is further assisted by government inputs and investments in genomics and molecular biology researches.

Major Market Players in PCR technologies

In the PCR technologies market, the following players hold maximum value shares. They are: F. Hoffman-La Roche Ltd. is headquartered in Switzerland, Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. in (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), and Standard Biotools (U.S.), Lonza (Switzerland), Danaher Corporation (U.S.), Abbott Laboratories (U.S.), Merck KGaA (Germany), Bioneer Corporation (South Korea), PerkinElmer Inc. (U.S.), Hologic Inc. (U.S.), Sansure Biotech Inc. (China), Becton, Dickinson and Company (U.S.), and Analytik Jena AG (Germany).

Don’t miss out on business opportunities in PCR Technologies Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]